Sponsored by:
European regulatory landscape: Demystifying new Qualified Person (QP) requirements for Supplying medicine in the EU and UK
Qualified persons (QPs) play an essential role in the European clinical trial supply chain.
To help drug sponsors understand and overcome the regulatory hurdles and expedite time to clinic, this paper provides critical direction and support
